Effect of Empagliflozin on Multiple Biomarkers in Heart Failure: Insights From the Empire Heart Failure Trial

Circ Heart Fail. 2022 Aug;15(8):e009333. doi: 10.1161/CIRCHEARTFAILURE.121.009333. Epub 2022 Apr 21.
No abstract available

Keywords: biomarkers; clinical trial; heart failure; sodium-glucose transporter 2 inhibitors; therapeutics.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzhydryl Compounds* / pharmacology
  • Biomarkers
  • Clinical Trials as Topic
  • Glucosides* / pharmacology
  • Heart Failure* / diagnosis
  • Heart Failure* / drug therapy
  • Humans

Substances

  • Benzhydryl Compounds
  • Biomarkers
  • Glucosides
  • empagliflozin

Associated data

  • ClinicalTrials.gov/NCT03198585